American Heart Journal

Slides:



Advertisements
Similar presentations
Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated.
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7.
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,
Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.
Automatic Optimization of Cardiac Resynchronization Therapy Using SonR—Rationale and Design of the Clinical Trial of the SonRtip Lead and Automatic AV-VV.
Total arterial revascularization of triple vessel coronary disease based on combined internal thoracic and radial artery grafts  Robert H. Habib, PhD,
Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.
Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice  Manesh R.
Robert Roberts, MD, FRCPC, MACC  Canadian Journal of Cardiology 
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Manuel J. Antunes, MD, PhD, DSc 
National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.
Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.
Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)  Emily C. O’Brien, PhD,
The Demise of Morphine Oxygen Nitroglycerin Aspirin (MONA)
The Latest Lipid Guidelines:
Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B
Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention  Erin D. Michos, MD, MHS, Michael J. Blaha,
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs  Lauren A. Beste, MD, MSc,
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F
Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs  Lauren A. Beste, MD, MSc,
Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E
New Pathways in Lipid Care
Improving Appropriate Access to PCSK9 Inhibitors
Jane S. Saczynski, PhD, Darleen Lessard, MS, Frederick A
Updates in Cardiovascular Medicine
Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary  Terry A. Jacobson, MD, Matthew.
Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Punkaj Gupta, MBBS, Mallikarjuna Rettiganti, PhD, Jeffrey M
William M. DeCampli, MD, PhD 
The Journal of Thoracic and Cardiovascular Surgery
Volume 11, Issue 2, Pages (February 2014)
Comparison of recovery after mitral valve repair and replacement
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Conduit conundrum: If not two, why three?
Aditya K. Kaza, MD  The Journal of Thoracic and Cardiovascular Surgery 
Benjamin G. Arenson, BSc, Lindsey A. MacDonald, BSc, Hilary P
Fixing the supply problem
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Kevin Bridge, MD, MSPH, Robert Saeid Farivar, MD, PhD 
Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W
John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J
The Journal of Thoracic and Cardiovascular Surgery
The Ross procedure: Time to reevaluate the guidelines
Commentary: Points to ponder—Perioperative antithrombotic therapy in neonates with congenital heart disease…more harm than good?  Mary Patricia Massicotte,
Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD 
The harder one looks, the more one finds
Innovation in cardiothoracic surgical training
Decongestive Treatment of Acute Decompensated Heart Failure: Cardiorenal Implications of Ultrafiltration and Diuretics  Benjamin J. Freda, DO, Mara Slawsky,
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
The continuing challenge of congenital heart disease in China
The advent of thoracic endovascular aortic repair is associated with broadened treatment eligibility and decreased overall mortality in traumatic thoracic.
The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids  Paul.
George D. Lilly 1906–1988 Journal of Vascular Surgery
American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons  Richard J.
Preoperative PFTs: The answer is blowing in the wind
Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience  Tirone E. David, MD, Susan Armstrong, MSc, Joan.
Contemporary outcomes of complete atrioventricular septal defect repair: Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database 
The Journal of Thoracic and Cardiovascular Surgery
Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel.
Presentation transcript:

American Heart Journal Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project  Paul L. Hess, MD, MHS, Kevin Kennedy, MS, Michael Cowherd, MD, Salim S. Virani, MD, PhD, Frederick A. Masoudi, MD, MSPH, Ann Marie Navar, MD, PhD, Robert W. Yeh, MD, MSc, P. Michael Ho, MD, PhD, Thomas M. Maddox, MD, MSc  American Heart Journal  DOI: 10.1016/j.ahj.2017.09.004 Copyright © 2017 Terms and Conditions

Figure Proportion of patients with ASCVD potentially eligible for PCSK9 inhibitor therapy according to LDL-C treatment thresholds and statin intensity. American Heart Journal DOI: (10.1016/j.ahj.2017.09.004) Copyright © 2017 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.